Revision: Jan. 7, 2026, 5:06 p.m.
SB 650 - AS INTRODUCED
2026 SESSION
26-2089
05/09
SENATE BILL 650
AN ACT relative to use of cannabis products for therapeutic purposes by alternative treatment centers.
SPONSORS: Sen. Rochefort, Dist 1; Sen. Innis, Dist 7; Sen. McGough, Dist 11; Sen. Sullivan, Dist 18; Sen. Murphy, Dist 16; Rep. Polozov, Merr. 10; Rep. Weber, Ches. 5; Rep. C. McGuire, Merr. 27; Rep. Ebel, Merr. 7
COMMITTEE: Judiciary
-----------------------------------------------------------------
ANALYSIS
This bill permits alternative treatment centers to use certain cannabis products for therapeutic purposes.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
26-2089
05/09
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty-Six
AN ACT relative to use of cannabis products for therapeutic purposes by alternative treatment centers.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Use of Cannabis for Therapeutic Purposes; Definitions; Cannabis. Amend RSA 126-X:1, III to read as follows:
III. "Cannabis" means all parts of any plant of the Cannabis genus of plants, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, salt, derivative, mixture, or preparation of such plant, its seeds, or resin. Such term shall not include the mature stalks of such plants, fiber produced from such stalks, oil, or cake made from the seeds of such plants, any other compound, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil or cake, or the sterilized seeds of such plants which are incapable of germination. In this chapter, cannabis shall not include hemp grown, processed, marketed, or sold under RSA 439-A, except as provided in RSA 126-X:8, XIX.
2 New Paragraph; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements. Amend RSA 126-X:8 by inserting after paragraph XVIII the following new paragraph:
XIX.(a) An alternative treatment center may acquire and may use in the manufacture of cannabis concentrate and cannabis-infused products, CBD, and other hemp-derived nonintoxicating cannabinoids not produced by an alternative treatment center in New Hampshire. All such non-intoxicating cannabinoids, and all cannabis concentrate and cannabis-infused products manufactured from such non-intoxicating cannabinoids, shall be tested for contaminants and cannabinoid profile in accordance with this chapter and department rules.
(b) An alternative treatment center shall not use products that are derived from hemp which contain natural tetrahydrocannabinol (THC) greater than 0.3 percent on a dry weight basis, which appear in any formulation, including delta-8 THC, delta-9 THC, or any other THC isomer variant, or which contain synthetic THC in any formulation and in any amount.
3 Effective Date. This act shall take effect 60 days after its passage.